Roles of lipoxin A4 receptor activation and anti-interleukin-1β antibody on the toll-like receptor 2/mycloid differentiation factor 88/nuclear factor-κB pathway in airway inflammation induced by ovalbumin

Molecular Medicine Reports

Volumn 12, Issue 1, 2015, Pages 895-904

  Kong, Xia ^a,b   Wu, Sheng Hua ^a   Zhang, Li ^b   Chen, Xiao Qing ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Interleukin 1 ; Lipoxin A4; Mycloid differentiation factor 88; Nuclear factor B; Ovalbumin; Toll like receptor 2

Indexed keywords

7 TRIHYDROXYHEPTANOIC ACID METHYL ESTER; ANTIINFLAMMATORY AGENT; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA ANTIBODY; INTERLEUKIN 4; INTERLEUKIN 8; MYELOID DIFFERENTIATION FACTOR 88; OVALBUMIN; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG; 5(S),6(R)-7-TRIHYDROXYHEPTANOIC ACID, METHYL ESTER; ANTIASTHMATIC AGENT; FORMYL PEPTIDE RECEPTOR 2, MOUSE; FORMYLPEPTIDE RECEPTOR; HEPTANOIC ACID DERIVATIVE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOXIN; LIPOXIN A; MONOCLONAL ANTIBODY; MYD88 PROTEIN, MOUSE; TLR2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL SWELLING; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIMERIZATION; EOSINOPHIL COUNT; EXPERIMENTAL ASTHMA; INFLAMMATORY CELL; KERATINOCYTE; LEUKOCYTE COUNT; LUNG LAVAGE; LUNG PARENCHYMA; LYMPHOCYTE COUNT; MALE; MOUSE; NEUTROPHIL COUNT; NONHUMAN; OVALBUMIN-INDUCED AIRWAY INFLAMMATION; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; ASTHMA; BAGG ALBINO MOUSE; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; CHEMICALLY INDUCED; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY;

MUS;

ANIMALS; ANTI-ASTHMATIC AGENTS; ANTIBODIES, MONOCLONAL; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; GENE EXPRESSION REGULATION; HEPTANOIC ACIDS; INTERLEUKIN-1BETA; INTERLEUKIN-4; INTERLEUKIN-6; INTERLEUKIN-8; LIPOXINS; MALE; MICE; MICE, INBRED BALB C; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; OVALBUMIN; RECEPTORS, FORMYL PEPTIDE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2;

EID: 84926685582     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.3443     Document Type: Article

References (39)

1. WHO/NHLBI Workshop report. Global strategy for asthma management and prevention. National Institutes of Health/National Heart. Lung and Blood Institue. NIH Publication No. 02-3659, Bethesda, 2005.
2. Leff AR: Role of leukotrienes in bronchial hyperresponsiveness and cellular responses in airways. Am J Respir Crit Care Med 161: S125-S132, 2000.
3. Broide DH, Lotz M, Cuomo AJ, Coburn DA, Federman EC and Wasserman SI: Cytokines in symptomatic asthma airways. J Allergy Clin Immunol 89: 958-967, 1992.
4. Krause K, Metz M, Makris M, Zuberbier T and Maurer M: The role of interleukin-1 in allergy-related disorders. Curr Opin Allergy Clin Immunol 12: 477-484, 2012.
5. Luster AD and Tager AM: T-cell trafficking in asthma: lipid mediators grease the way. Nat Rev Immunol 4: 711-724, 2004.
6. O'Byrne PM: Leukotriene bronchoconstriction induced by allergen and exercise. Am J Respir Crit Care Med 161: S68-S72, 2000.
7. Serhan CN: Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution. Prostaglandins Other Lipid Mediat 68: 433-455, 2002.
8. Lee TH, Lympany P, Crea AK and Spur BW: Inhibition of leukotriene B4-induced neutrophil migration by lipoxin A4: structure-function relationships. Biochem Biophys Res Commun 180: 1416-1421, 1991.
9. Wu SH, Liao PY, Yin PL, Zhang YM and Dong L: Elevated expressions of 15-lipoxygenase and lipoxin A4 in children with acute poststreptococcal glomerulonephritis. Am J Pathol 174: 115-122, 2009.
10. Levy BD, Lukacs NW, Berlin AA, Schmidt B, Guilford WJ, Serhan CN and Parkinson JF: Lipoxin A4 stable analogs reduce allergic airway responses via mechanisms distinct from CysLT1 receptor antagonism. FASEB J 21: 3877-3884, 2007.
11. Levy BD, De Sanctis GT, Devchand PR, Kim E, Ackerman K, Schmidt BA, Szczeklik W, Drazen JM and Serhan CN: Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A4. Nat Med 8: 1018-1023, 2002.
12. Bonnans C, Vachier I, Chavis C, Godard P, Bousquet J and Chanez P: Lipoxins are potential endogenous antiinflammatory mediators in asthma. Am J Respir Crit Care Med 165: 1531-1535, 2002.
13. Wu SH, Liao PY, Dong L and Chen ZQ: Signal pathway involved in inhibition by lipoxin A(4) of production of interleukins induced in endothelial cells by lipopolysaccharide. Inflamm Res 57: 430-437, 2008.
14. Faure E, Equils O, Sieling PA, Thomas L, Zhang FX, Kirschning CJ, Polentarutti N, Muzio M and Arditi M: Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor 4 (TLR4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. J Biol Chem 275: 11058-11063, 2000.
15. Hoth JJ, Wells JD, Brownlee NA, Hiltbold EM, Meredith JW, McCall CE and Yoza BK: Toll-like receptor 4-dependent responses to lung injury in a murine model of pulmonary contusion. Shock 31: 376-381, 2009.
16. Sabroe I, Parker LC, Wilson AG, Whyte MK and Dower SK: Toll-like receptors: their role in allergy and non-allergic inflammatory disease. Clin Exp Allergy 32: 984-989, 2002.
17. Redecke V, Häcker H, Datta SK, Fermin A, Pitha PM, Broide DH and Raz E: Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J Immunol 172: 2739-2743, 2004.
18. Eisenbarth SC and Flavell RA: Innate instruction of adaptive immunity revisited: the inflammasome. EMBO Mol Med 1: 92-98, 2009.
19. Velasco G, Campo M, Manrique OJ, Bellou A, He H, Arestides RS, Schaub B, Perkins DL and Finn PW: Toll-like receptor 4 or 2 agonists decrease allergic inflammation. Am J Respir Cell Mol Biol 32: 218-224, 2005.
20. Wu SH, Wu XH, Liao PY and Dong L: Signal transduction involved in protective effects of 15(R/S)-methyl-lipoxin A(4) on mesangioproliferative nephritis in rats. Prostaglandins Leukot Essent Fatty Acids 76: 173-180, 2007.
21. Zhang L, Zhang X, Wu P, Li H, Jin S, Zhou X, Li Y, Ye D, Chen B and Wan J: BML-111, a lipoxin receptor agonist, modulates the immune response and reduces the severity of collagen-induced arthritis. Inflamm Res 57: 157-162, 2008.
22. Hecht I, Rong J, Sampaio AL, Hermesh C, Rutledge C, Shemesh R, Toporik A, Beiman M, Dassa L, et al: A novel peptide agonist of formyl-peptide receptor-like 1 (ALX) displays anti-inflammatory and cardioprotective effects. J Pharmacol Exp Ther 328: 426-434, 2009.
23. Cho JY, Miller M, Baek KJ, Castaneda D, Nayar J, Roman M, Raz E and Broide DH: Immunostimulatory DNA sequences inhibit respiratory syncytial viral load, airway inflammation, and mucus secretion. J Allergy Clin Immunol 108: 697-702, 2001.
24. Loiarro M, Capolunghi F, Fantò N, Gallo G, Campo S, Arseni B, Carsetti R, Carminati P, De Santis R, et al: Pivotal advance: inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound. J Leukoc Biol 82: 801-810, 2007.
25. Gewirtz AT, Collier-Hyams LS, Young AN, Kucharzik T, Guilford WJ, Parkinson JF, Williams IR, Neish AS and Madara JL: Lipoxin a4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis. J Immunol 168: 5260-5267, 2002.
26. Wu SH, Liu B, Dong L and Wu HJ: NF-kappaB is involved in inhibition of lipoxin A4 on dermal inflammation and hyperplasia induced by mezerein. Exp Dermatol 19: e286-e288, 2010.
27. Kaisho T and Akira S: Toll-like receptor function and signaling. J Allergy Clin Immunol 117: 979-987, 2006.
28. Li X and Qin JJ: Modulation of Toll-interleukin 1 receptor mediated signaling. J Mol Med (Berl) 83: 258-266, 2005.
29. Lee CC, Lai YT, Chang HT, Liao JW, Shyu WC, Li CY and Wang CN: Inhibition of high-mobility group box 1 in lung reduced airway inflammation and remodeling in a mouse model of chronic asthma. Biochem Pharmacol 86: 940-949, 2013.
30. Ferreira DS, Annoni R, Silva LF, Buttignol M, Santos AB, Medeiros MC, Andrade LN, Yick CY, Sterk PJ, et al: Toll-like receptors 2, 3 and 4 and thymic stromal lymphopoietin expression in fatal asthma. Clin Exp Allergy 42: 1459-1471, 2012.
31. Simpson JL, Grissell TV, Douwes J, Scott RJ, Boyle MJ and Gibson PG: Innate immune activation in neutrophilic asthma and bronchiectasis. Thorax 62: 211-218, 2007.
32. Bauer C, Kielian T, Wyatt TA, Romberger DJ, West WW, Gleason AM and Poole JA: Myeloid differentiation factor 88-dependent signaling is critical for acute organic dust-induced airway inflammation in mice. Am J Respir Cell Mol Biol 48: 781-789, 2013.
33. Krause K, Metz M, Makris M, Zuberbier T and Maurer M: The role of interleukin-1 in allergy-related disorders. Curr Opin Allergy Clin Immunol 12: 477-484, 2012.
34. Nakae S, Komiyama Y, Yokoyama H, Nambu A, Umeda M, Iwase M, Homma I, Sudo K, Horai R, et al: IL-1 is required for allergen-specific Th2 cell activation and the development of airway hypersensitivity response. Int Immunol 15: 483-490, 2003.
35. Sim TC, Hilsmeier KA, Reece LM, Grant JA and Alam R: Interleukin-1 receptor antagonist protein inhibits the synthesis of IgE and proinflammatory cytokines by allergen-stimulated mononuclear cells. Am J Respir Cell Mol Biol 11: 473-479, 1994.
36. Nagarkar DR, Poposki JA, Comeau MR, Biyasheva A, Avila PC, Schleimer RP and Kato A: Airway epithelial cells activate TH2 cytokine production in mast cells through IL-1 and thymic stromal lymphopoietin. Allergy Clin Immunol 130: 225-232, 2012.
37. Wei-xu H, Qin X, Zhu W, Yuan-yi C, Li-feng Z, et al: Therapeutic potential of anti-IL-1β IgY in guinea pigs with allergic asthma induced by ovalbumin. Mol Immunol 58: 139-149, 2014.
38. Campo GM, Avenoso A, D'Ascola A, Scuruchi M, Prestipino V, Nastasi G, Calatroni A and Campo S: Adenosine A2A receptor activation and hyaluronan fragment inhibition reduce inflammation in mouse articular chondrocytes stimulated with interleukin-1β. FEBS J 279: 2120-2133, 2012.
39. Christie PE, Spur BW and Lee TH: The effects of lipoxin A4 on airway responses in asthmatic subjects. Am Rev Respir Dis 145: 1281-1284, 1992.